CASI Pharmaceuticals (CASI) Non-Current Receivables (2023 - 2024)
Historic Non-Current Receivables for Pharmaceuticals (CASI) over the last 2 years, with Q2 2024 value amounting to $963.0 million.
- Pharmaceuticals' Non-Current Receivables changed N/A to $963.0 million in Q2 2024 from the same period last year, while for Jun 2024 it was $963.0 million, marking a year-over-year change of. This contributed to the annual value of $587.0 million for FY2023, which is N/A changed from last year.
- According to the latest figures from Q2 2024, Pharmaceuticals' Non-Current Receivables is $963.0 million.
- In the past 5 years, Pharmaceuticals' Non-Current Receivables registered a high of $963.0 million during Q2 2024, and its lowest value of $587.0 million during Q4 2023.